123 related articles for article (PubMed ID: 38349229)
1. Molecular analysis of endobronchial ultrasound needle aspirates in patients with non-small cell lung cancer: Results from the SCOPE database.
Vakil E; Dumoulin E; Stollery D; Gillson AM; MacEachern P; Dhaliwal I; Mitchell M; Li P; Schieman C; Romatowski N; Chee AC; Tyan CC; Fortin M; Hergott CA; Tremblay A
Cytopathology; 2024 May; 35(3):378-382. PubMed ID: 38349229
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience.
Karadzovska-Kotevska M; Brunnström H; Kosieradzki J; Ek L; Estberg C; Staaf J; Barath S; Planck M
PLoS One; 2022; 17(2):e0263342. PubMed ID: 35108331
[TBL] [Abstract][Full Text] [Related]
3. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
Esterbrook G; Anathhanam S; Plant PK
Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
[TBL] [Abstract][Full Text] [Related]
4. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration samples for programmed death ligand-1 testing in non-small cell lung cancer, the Bristol experience.
Hardy J; Bhatt N; Medford ARL
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e32-e38. PubMed ID: 33870634
[TBL] [Abstract][Full Text] [Related]
5. Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer.
Cicek T; Ozturk A; Yılmaz A; Aktas Z; Demirag F; Akyurek N
Clin Respir J; 2019 Feb; 13(2):92-97. PubMed ID: 30582673
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Programmed Death Ligand-1 Immunohistochemical Staining Between Endobronchial Ultrasound Transbronchial Needle Aspiration and Resected Lung Cancer Specimens.
Sakata KK; Midthun DE; Mullon JJ; Kern RM; Nelson DR; Edell ES; Schiavo DN; Jett JR; Aubry MC
Chest; 2018 Oct; 154(4):827-837. PubMed ID: 30059678
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of lung cancer biomarkers profile for the decision of targeted therapy in EBUS-TBNA cytological samples.
Gürün Kaya A; Çiledağ A; Erol S; Öz M; Doğan Mülazımoğlu D; Işık Ö; Özakıncı H; Çiftçi F; Şen E; Ceyhan K; Kaya A; Karnak D; Çelik G; İsmail S
Scott Med J; 2022 Feb; 67(1):18-27. PubMed ID: 35147461
[TBL] [Abstract][Full Text] [Related]
8. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed?
Yarmus L; Akulian J; Gilbert C; Feller-Kopman D; Lee HJ; Zarogoulidis P; Lechtzin N; Ali SZ; Sathiyamoorthy V
Ann Am Thorac Soc; 2013 Dec; 10(6):636-43. PubMed ID: 24079724
[TBL] [Abstract][Full Text] [Related]
9. Adequacy of Samples Obtained by Endobronchial Ultrasound with Transbronchial Needle Aspiration for Molecular Analysis in Patients with Non-Small Cell Lung Cancer. Systematic Review and Meta-Analysis.
Labarca G; Folch E; Jantz M; Mehta HJ; Majid A; Fernandez-Bussy S
Ann Am Thorac Soc; 2018 Oct; 15(10):1205-1216. PubMed ID: 30011388
[TBL] [Abstract][Full Text] [Related]
10. Clinical performance of endobronchial ultrasound-guided transbronchial needle aspiration for assessing programmed death ligand-1 expression in nonsmall cell lung cancer.
Biswas A; Leon ME; Drew P; Fernandez-Bussy S; Furtado LV; Jantz MA; Mehta HJ
Diagn Cytopathol; 2018 May; 46(5):378-383. PubMed ID: 29476608
[TBL] [Abstract][Full Text] [Related]
11. Handling and standardization of EBUS needle aspiration in NSCLC patients: The value of the cell block, a monoinstitutional experience.
Parente P; Carbonelli C; Biancofiore G; Sukthi A; Di Micco CM; Vairo M; Fuso P; Taurchini M; Graziano P
Thorac Cancer; 2022 Sep; 13(17):2480-2488. PubMed ID: 35868633
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of endobronchial ultrasound-guided transbronchial needle aspiration for staging of non-small cell lung cancer.
Chung K; Bentel J; Laycock A
Diagn Cytopathol; 2024 May; 52(5):254-263. PubMed ID: 38348554
[TBL] [Abstract][Full Text] [Related]
13. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients.
Navani N; Brown JM; Nankivell M; Woolhouse I; Harrison RN; Jeebun V; Munavvar M; Ng BJ; Rassl DM; Falzon M; Kocjan G; Rintoul RC; Nicholson AG; Janes SM
Am J Respir Crit Care Med; 2012 Jun; 185(12):1316-22. PubMed ID: 22505743
[TBL] [Abstract][Full Text] [Related]
14. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
[TBL] [Abstract][Full Text] [Related]
15. Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration.
Casadio C; Guarize J; Donghi S; Di Tonno C; Fumagalli C; Vacirca D; Dell'Orto P; De Marinis F; Spaggiari L; Viale G; Barberis M
Am J Clin Pathol; 2015 Oct; 144(4):629-34. PubMed ID: 26386084
[TBL] [Abstract][Full Text] [Related]
16. Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non-small-cell lung cancer.
Folch E; Yamaguchi N; VanderLaan PA; Kocher ON; Boucher DH; Goldstein MA; Huberman MS; Kent MS; Gangadharan SP; Costa DB; Majid A
J Thorac Oncol; 2013 Nov; 8(11):1438-1444. PubMed ID: 24128714
[TBL] [Abstract][Full Text] [Related]
17. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Re-biopsy in Previously Treated Lung Cancer.
Kim J; Kang HJ; Moon SH; Lee JM; Kim HY; Lee GK; Lee JS; Hwangbo B
Cancer Res Treat; 2019 Oct; 51(4):1488-1499. PubMed ID: 30913867
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial.
Navani N; Nankivell M; Lawrence DR; Lock S; Makker H; Baldwin DR; Stephens RJ; Parmar MK; Spiro SG; Morris S; Janes SM;
Lancet Respir Med; 2015 Apr; 3(4):282-9. PubMed ID: 25660225
[TBL] [Abstract][Full Text] [Related]
19. [Feasibility of assessing EGFR mutation and others using samples obtained by EBUS transbronchial needle aspiration].
Boulanger S; Delattre C; Descarpentries C; Escande F; Bouchindhomme B; Copin MC; Dhalluin X; Scherpereel A; Ramon PP; Cortot A; Fournier C
Rev Mal Respir; 2013 May; 30(5):351-6. PubMed ID: 23746811
[TBL] [Abstract][Full Text] [Related]
20. Endobronchial ultrasound-guided re-biopsy of non-small cell lung cancer with acquired resistance after EGFR tyrosine kinase inhibitor treatment.
Hong KS; Cho J; Jang JG; Jang MH; Ahn JH
Thorac Cancer; 2023 Feb; 14(4):363-370. PubMed ID: 36525475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]